Comparison of Occlusive and Classical Hypertrophy Training in Terms of Thickness and Stiffness of The Muscle

NCT ID: NCT03149133

Last Updated: 2017-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-04-05

Study Completion Date

2017-08-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Occlusive or ischemic training is a type of strength training which is becoming more and more popular every day. The safety, efficacy and detailed description about the use of occlusive training is well documented in the literature. However, the effects on hypertrophy and the stiffness of the muscle tissue are not studied. We aimed to measure these changes by ultrasound technology in a randomized controlled design.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients were randomized into classical hypertrophy and occlusive hypertrophy groups. The participants are free from any systemic disease, infection or recent injury. Both groups perform hypertrophy training with different intensities. The outcome measures are; thickness determined by B-mode ultrasound and stiffness by shear-wave elastography. Comparison of both groups will be made.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Muscle Tightness Hypertrophy Occlusion Vein

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial
Primary Study Purpose

SCREENING

Blinding Strategy

DOUBLE

Investigators Outcome Assessors
The investigator and outcome assessor are blinded to groups.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Classical Hypertrophy

The classical hypertrophy group performs strength training with 75-80% of 1-Repetition Maximum.

Group Type EXPERIMENTAL

Heavy hypertrophy training

Intervention Type OTHER

Training with 75-80 % of 1-RM

Occlusive Training

The occlusive hypertrophy group performs strength training with %35-50 of 1-Repetition Maximum.

Group Type EXPERIMENTAL

Light hypertrophy training

Intervention Type OTHER

Training with 35-50 % of 1-RM

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Heavy hypertrophy training

Training with 75-80 % of 1-RM

Intervention Type OTHER

Light hypertrophy training

Training with 35-50 % of 1-RM

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy recreational athletes

Exclusion Criteria

* Any kind of systemic disorder
* Active or chronic infection
* Recent (last 6 months) musculoskeletal injury
* Performed strength training at last 72 hours
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

ÖMER BATIN GÖZÜBÜYÜK

M.D.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istanbul University

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016/248

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.